IFNG and esophageal squamous cell carcinoma: To further determine whether patients with ESCC in the FAT/FRY subgroup were potential beneficiaries of ICIs, we first evaluated the expression of an IFN-γ signature, which was previously reported to correlate with a better response to ICIs (40).